These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The use of dipeptide derivatives of 5-aminolaevulinic acid promotes their entry to tumor cells and improves tumor selectivity of photodynamic therapy. Di Venosa G; Vallecorsa P; Giuntini F; Mamone L; Batlle A; Vanzuli S; Juarranz A; MacRobert AJ; Eggleston IM; Casas A Mol Cancer Ther; 2015 Feb; 14(2):440-51. PubMed ID: 25519699 [TBL] [Abstract][Full Text] [Related]
4. Peptide-targeted dendrimeric prodrugs of 5-aminolevulinic acid: A novel approach towards enhanced accumulation of protoporphyrin IX for photodynamic therapy. Tewari KM; Dondi R; Yaghini E; Pourzand C; MacRobert AJ; Eggleston IM Bioorg Chem; 2021 Apr; 109():104667. PubMed ID: 33611140 [TBL] [Abstract][Full Text] [Related]
5. Poly(L-histidine)-tagged 5-aminolevulinic acid prodrugs: new photosensitizing precursors of protoporphyrin IX for photodynamic colon cancer therapy. Johnson RP; Chung CW; Jeong YI; Kang DH; Suh H; Kim I Int J Nanomedicine; 2012; 7():2497-512. PubMed ID: 22679363 [TBL] [Abstract][Full Text] [Related]
6. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevulinic acid-n-pentylester. Gerscher S; Connelly JP; Beijersbergen Van Henegouwen GM; MacRobert AJ; Watt P; Rhodes LE Br J Dermatol; 2001 May; 144(5):983-90. PubMed ID: 11359385 [TBL] [Abstract][Full Text] [Related]
7. Photodynamic anticancer activity evaluation of novel 5-aminolevulinic acid and 3-hydroxypyridinone conjugates. Zhang J; Yuan S; Fan M; Wang K; Guo J; Zang A; Ren J; Su W; Zhang C; Xie Y Bioorg Med Chem; 2024 May; 105():117726. PubMed ID: 38626642 [TBL] [Abstract][Full Text] [Related]
8. Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug. Curnow A; Perry A; Wood M Photodiagnosis Photodyn Ther; 2019 Mar; 25():157-165. PubMed ID: 30553949 [TBL] [Abstract][Full Text] [Related]
9. [5-Aminolevulinic acid esters based photodynamic therapy]. Zhang S; Zhang Z; Jiang D Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Jun; 19(2):310-4. PubMed ID: 12224308 [TBL] [Abstract][Full Text] [Related]
10. Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin. Kloek J; Akkermans W; Beijersbergen van Henegouwen GM Photochem Photobiol; 1998 Jan; 67(1):150-4. PubMed ID: 9477773 [TBL] [Abstract][Full Text] [Related]
11. An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy. Anayo L; Magnussen A; Perry A; Wood M; Curnow A Lasers Surg Med; 2018 Jul; 50(5):552-565. PubMed ID: 29603761 [TBL] [Abstract][Full Text] [Related]
12. Zwitterionic stealth peptide-capped 5-aminolevulinic acid prodrug nanoparticles for targeted photodynamic therapy. Wu J; Lin Y; Li H; Jin Q; Ji J J Colloid Interface Sci; 2017 Jan; 485():251-259. PubMed ID: 27676086 [TBL] [Abstract][Full Text] [Related]
13. In vitro/in vivo correlations between transdermal delivery of 5-aminolaevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation. Tsai JC; Chen IH; Wong TW; Lo YL Br J Dermatol; 2002 May; 146(5):853-62. PubMed ID: 12000384 [TBL] [Abstract][Full Text] [Related]
14. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin. Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589 [TBL] [Abstract][Full Text] [Related]
15. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer. Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092 [TBL] [Abstract][Full Text] [Related]
17. Novel potential photodynamic therapy strategy using 5-Aminolevulinic acid for ovarian clear-cell carcinoma. Teshigawara T; Mizuno M; Ishii T; Kitajima Y; Utsumi F; Sakata J; Kajiyama H; Shibata K; Ishizuka M; Kikkawa F Photodiagnosis Photodyn Ther; 2018 Mar; 21():121-127. PubMed ID: 29196245 [TBL] [Abstract][Full Text] [Related]
18. Prodrugs of 5-aminolevulinic acid for photodynamic therapy. Kloek J; Beijersbergen van Henegouwen Photochem Photobiol; 1996 Dec; 64(6):994-1000. PubMed ID: 8972644 [TBL] [Abstract][Full Text] [Related]
19. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy. Choudry K; Brooke RC; Farrar W; Rhodes LE Br J Dermatol; 2003 Jul; 149(1):124-30. PubMed ID: 12890205 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of new 5-aminolevulinic acid derivatives as prodrugs of protoporphyrin for photodynamic therapy. Zhu W; Gao YH; Song CH; Lu ZB; Namulinda T; Han YP; Yan YJ; Wang LX; Chen ZL Photochem Photobiol Sci; 2017 Nov; 16(11):1623-1630. PubMed ID: 28933502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]